Savara (SVRA) Other Non Operating Income (2010 - 2026)

Savara (SVRA) reported Other Non Operating Income of $1.7 million for Q1 2026, down 5.01% year-over-year from $1.8 million in Q1 2025, and down 61.12% quarter-over-quarter from $4.4 million in Q4 2025.

Savara (SVRA) Other Non Operating Income (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Other Non Operating Income data on file, last reported at $1.7 million in Q1 2026.

  • Other Non Operating Income for Q1 2026 came in at $1.7 million, down 5.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 million (up 147.59% YoY), and the FY2025 annual result was $4.7 million, up 9135.29% from the prior year.
  • Other Non Operating Income declined to $1.7 million in Q1 2026 per SVRA's latest filing, from $4.4 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $4.4 million in Q4 2025 and troughed at -$254000.0 in Q1 2022.
  • A 5-year average of $715588.2 and a median of $146000.0 in 2025 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2022 and 2023: Other Non Operating Income tumbled 345.61% in 2022, then surged 18162.5% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $668000.0 in 2022, then plunged by 98.2% to $12000.0 in 2023, then soared by 1708.33% to $217000.0 in 2024, then soared by 1922.12% to $4.4 million in 2025, then sank by 61.12% to $1.7 million in 2026.
  • Business Quant data shows SVRA's Other Non Operating Income at $1.7 million in Q1 2026, $4.4 million in Q4 2025, and $146000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Savara 1.39 Bn 1.39 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.71 Mn
Dec 31, 2025 4.39 Mn
Sep 30, 2025 146,000.00
Jun 30, 2025 1.04 Mn
Mar 31, 2025 1.80 Mn
Dec 31, 2024 217,000.00
Sep 30, 2024 -20,000.00
Jun 30, 2024 947,000.00
Mar 31, 2024 -21,000.00
Dec 31, 2023 12,000.00
Sep 30, 2023 1.45 Mn
Jun 30, 2023 33,000.00
Mar 31, 2023 29,000.00
Dec 31, 2022 668,000.00
Sep 30, 2022 -8,000.00
Jun 30, 2022 42,000.00
Mar 31, 2022 -254,000.00
Dec 31, 2021 -77,000.00
Sep 30, 2021 -574,000.00
Jun 30, 2021 -489,000.00